According to Aceso Life Science Group latest financial reports the cash on hand of 0474 is $77.24M, an decrease of 0.00% to 2022. At the end of 2022 company had $77.24M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $77.24M | 0.00% |
2022 | $77.24M | -23.41% |
2021 | $100.84M | 35.28% |
2020 | $74.54M | -65.23% |
2019 | $214.40M | - |